GCM
IDXX icon

Genus Capital Management’s Idexx Laboratories IDXX Stock Holding History

Genus Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338K Sell
642
-1,880
-75% -$1.05M 0.03% 175
2026
Q1 		$1.42M Sell
2,522
-9,480
-79% -$6.08M 0.16% 127
2025
Q4 		$8.12M Sell
12,002
-300
-2% -$204K 0.95% 39
2025
Q3 		$7.86M Buy
+12,302
New +$7.47M 0.91% 31

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Genus Capital Management's IDXX Position: Q2 2026 in Review

Genus Capital Management reduced its Idexx Laboratories (IDXX) stake by 75% in Q2 2026, selling an estimated $1.05M and leaving 642 shares worth $338K. The position accounts for 0.03% of the portfolio, ranked #175.

Genus Capital Management first reported a position in IDXX in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.12M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Genus Capital Management held 642 shares of Idexx Laboratories worth $338K as of Q2 2026.
  • Genus Capital Management sold 1,880 Idexx Laboratories shares in Q2 2026, an estimated $1.05M.
  • Idexx Laboratories made up 0.03% of Genus Capital Management's portfolio in Q2 2026, its #175 holding.
  • Genus Capital Management first reported a position in Idexx Laboratories in Q3 2025 and has held it in 4 quarters since.
  • Genus Capital Management's Idexx Laboratories position peaked at $8.12M in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.